Two years have passed since the US Supreme Court’s decision in Dobbs vs Jackson Women’s Health to overturn the constitutional protection for abortion rights. With President-elect Donald Trump set to return to the White House in January 2025, the uncertainty and fears around these rights have been heightened.
This month’s cover story explores the ethical, legal, and practical implications the US abortion restrictions on those involved in clinical trials, given the restrictions in some states may potentially expose trial sponsors to litigation.
Also in this issue, a feature looks at the actions Pfizer management took to thwart activist investor Starboard, which took a $1bn stake in Pfizer and challenged the company’s leadership in pursuit of a turnaround. Additionally, a comment article looks at how a recent investment by obesity and diabetes drug maker Eli Lilly in the UK may play out.
This month’s edition also includes a pharma event guide supplement, highlighting the key pharma industry events to look out for as we head into 2025 along with a look back at major events in 2024.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
